In this installment of Robert MacNeill’s (Envigo) column, Robert discusses the instability of drugs within samples and how to balance their instability against absorptive loss.
Current thinking on quantification of protein therapeutic pharmacokinetics and protein biomarkers in clinical studies
In this commentary, Kate Peng discusses the current thinking on quantification of protein therapeutic pharmacokinetics and protein biomarkers in clinical studies.
In this commentary, the authors discuss the benefits and challenges of using ‘ready-to-use’ cells from a frozen bank of uniform, tested, aliquots.
In December 2015, the Reid Bioanalytical Forum entered a new era with a new committee…
An editorial on where the Bioanalysis spotlight entitled – Microsampling: the road ahead has led to two years on.
In this Editorial, Tim Sangster takes a personal look at how microsampling has developed over the last couple of decades.
Press release summarizing recent Spotlight event on HRMS hosted by Bioanalysis Zone.
Influence of sample handling conditions on drug partitioning in blood: a major problem in PK studies?
In this Editorial the effect, on pharmacokinetics, of sampling plasma instead of whole blood is discussed.
In this Editorial the pros and cons of dried matrix spot sampling for cerebrospinal fluid analysis are discussed.
Self-sampling and quantitative analysis of DBS: can it shift the balance in over-burdened healthcare systems?
In this editorial the authors look at what is needed to provide a self-collection DBS protocol capable of producing quantitative data, using results from their work using self-sampled DBS samples to monitor therapeutic drug levels in volunteers taking cardiovascular medications.